Saturday, February 28, 2026

Music Director Abhijit Majumdar gradually taken off ventilator support

The health condition of renowned Odia music director Abhijit Majumdar, who is undergoing treatment at AIIMS Bhubaneswar, is showing slow but steady improvement

Continue reading

September 17, 2025
ENTERTAINMENT

Bhubaneswar: The health condition of renowned Odia music director Abhijit Majumdar, who is undergoing treatment at AIIMS Bhubaneswar, is showing slow but steady improvement.

Dr. Srikant Behera, ICU and ECMO specialist at AIIMS, said Majumdar’s pneumonia is improving and he is being gradually weaned off ventilator support. However, the 54-year-old composer’s neurological condition remains unchanged, and he continues to be in a comatose state. His renal and liver functions are reported to be normal, while his vitals are stable. A repeat MRI of the brain is scheduled for tomorrow.

Majumdar was admitted to the AIIMS emergency on September 4 in a comatose state and placed on ventilator support. He was later shifted to the ICU for further management. Doctors have diagnosed him with osmotic demyelination syndrome (both pontine and extrapontine), bilateral pneumonia, bloodstream infection, chronic liver disease, dyselectrolytemia, and nutritional deficiency.

A highly celebrated figure in Odisha’s music industry, Majumdar has composed over 700 songs across Odia and Sambalpuri films and albums. His notable works include ‘Love Story’, ‘Sister Sridevi’, ‘Golmaal Love’, ‘Sundargarh Ra Salman Khan’, and ‘Sriman Surdas’.

About the Author
Surya Narayan Pradhan

Surya Narayan Pradhan, the Senior Content Writer, has worked with Financial Express and Financial World in New Delhi prior to his association with OTV. (Twitter: @netizensurya).

728x90 Advertisement

You May Also Like


DISCLAIMER
All content on this website is the exclusive property of Eastern Media Limited. Any downloadable material, including but not limited to electronic or digital versions of the newspaper (e-paper) in any format, is provided solely for personal use. Unauthorized dissemination, distribution, circulation, or publication of any content or e-paper (whether in PDF or other formats) by any means, including on social media platforms, without prior authorization, permission, or license is strictly prohibited.